On Friday, Organogenesis Holdings Inc (NASDAQ: ORGO) opened at On Friday, higher 5.21% from the last session, before settling in for the closing price of $2.88. Price fluctuations for ORGO have ranged from $2.28 to $6.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 13.06%. Company’s average yearly earnings per share was noted 754.67% at the time writing. With a float of $64.40 million, this company’s outstanding shares have now reached $126.85 million.
Considering the fact that the conglomerate employs 869 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 74.89%, operating margin of -5.27%, and the pretax margin is -5.29%.
Organogenesis Holdings Inc (ORGO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Organogenesis Holdings Inc is 49.24%, while institutional ownership is 51.46%. The most recent insider transaction that took place on Jun 05 ’25, was worth 413,625. In this transaction Chief Admin. and Legal Officer of this company bought 142,379 shares at a rate of $2.91, taking the stock ownership to the 837,437 shares. Before that another transaction happened on Jun 04 ’25, when Company’s Chief Admin. and Legal Officer bought 100,863 for $2.82, making the entire transaction worth $284,716. This insider now owns 695,058 shares in total.
Organogenesis Holdings Inc (ORGO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 754.67% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Check out the current performance indicators for Organogenesis Holdings Inc (ORGO). In the past quarter, the stock posted a quick ratio of 3.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach 0.20 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Compared to the last year’s volume of 1.71 million, its volume of 1.0 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 68.82%. Additionally, its Average True Range was 0.25.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 10.24%, which indicates a significant decrease from 63.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.40% in the past 14 days, which was lower than the 161.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.88, while its 200-day Moving Average is $3.59. Nevertheless, the first resistance level for the watch stands at $3.13 in the near term. At $3.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.33. If the price goes on to break the first support level at $2.93, it is likely to go to the next support level at $2.84. Now, if the price goes above the second support level, the third support stands at $2.73.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
There are currently 126,854K shares outstanding in the company with a market cap of 384.37 million. Presently, the company’s annual sales total 482,040 K according to its annual income of 860 K. Last quarter, the company’s sales amounted to 86,690 K and its income totaled -18,840 K.
